Parkinson Hastalığı
Özet
Referanslar
Cardozo, L, Rovner, E, Wagg, et al. (Eds) Incontinence 7th Edition (2023). ICI-ICS. International Continence Society, Bristol UK, ISBN: 978-0-9569607-4-0.
Zheng Y, Cameron AP. Sleep and Overactive Bladder in Parkinson's Disease. Urol Clin North Am. 2024 May;51(2):197-207.
Sartori AM, Kessler TM, Castro-Díaz DM, et al. Summary of the 2024 Update of the European Association of Urology Guidelines on Neurourology. Eur Urol. 2024 Jun;85(6):543-555.
Li FF, Cui YS, Yan R, et al. Prevalence of lower urinary tract symptoms, urinary incontinence and retention in Parkinson's disease: A systematic review and meta-analysis. Front Aging Neurosci. 2022 Sep 12; 14:977572.
Staskin DS, Vardi Y, Siroky MB. Post-prostatectomy continence in the parkinsonian patient: the significance of poor voluntary sphincter control. J Urol. 1988 Jul;140(1):117-8. doi: 10.1016/s0022-5347(17)41501-1. PMID: 2454326.
Roth, B., Studer, U.E., Fowler, C.J., Kessler, T.M. Benign prostatic obstruction and Parkinson’s disease – should transurethral resection of the prostate be avoided? J Urol. 2009 May;181(5):2209–2213.
Liao, L., & Madersbacher, H. (2019). Neurourology theory and Practice. Springer Netherlands.
Moussa, M., Abou Chakra, M., Badnji, D., et al. Urological care in Parkinson’s disease patients. Arch Ital Urol Androl. 2022;94(1):107–116.
McClurg D, Panicker J, Walker RW, et al. Stimulation of the tibial nerve: a protocol for a multicentred randomised controlled trial for urinary problems associated with Parkinson's disease-STARTUP. BMJ Open. 2020 Feb 17;10(2).
Kessler TM, La Framboise D, Trelle S, et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and metaanalysis. Eur Urol. 2010 Dec;58(6):865-74.
Peters KM, Kandagatla P, Killinger KA, et al. Clinical outcomes of sacral neuromodulation in patients with neurologic conditions. Urology. 2013 Apr;81(4):738–43.
Referanslar
Cardozo, L, Rovner, E, Wagg, et al. (Eds) Incontinence 7th Edition (2023). ICI-ICS. International Continence Society, Bristol UK, ISBN: 978-0-9569607-4-0.
Zheng Y, Cameron AP. Sleep and Overactive Bladder in Parkinson's Disease. Urol Clin North Am. 2024 May;51(2):197-207.
Sartori AM, Kessler TM, Castro-Díaz DM, et al. Summary of the 2024 Update of the European Association of Urology Guidelines on Neurourology. Eur Urol. 2024 Jun;85(6):543-555.
Li FF, Cui YS, Yan R, et al. Prevalence of lower urinary tract symptoms, urinary incontinence and retention in Parkinson's disease: A systematic review and meta-analysis. Front Aging Neurosci. 2022 Sep 12; 14:977572.
Staskin DS, Vardi Y, Siroky MB. Post-prostatectomy continence in the parkinsonian patient: the significance of poor voluntary sphincter control. J Urol. 1988 Jul;140(1):117-8. doi: 10.1016/s0022-5347(17)41501-1. PMID: 2454326.
Roth, B., Studer, U.E., Fowler, C.J., Kessler, T.M. Benign prostatic obstruction and Parkinson’s disease – should transurethral resection of the prostate be avoided? J Urol. 2009 May;181(5):2209–2213.
Liao, L., & Madersbacher, H. (2019). Neurourology theory and Practice. Springer Netherlands.
Moussa, M., Abou Chakra, M., Badnji, D., et al. Urological care in Parkinson’s disease patients. Arch Ital Urol Androl. 2022;94(1):107–116.
McClurg D, Panicker J, Walker RW, et al. Stimulation of the tibial nerve: a protocol for a multicentred randomised controlled trial for urinary problems associated with Parkinson's disease-STARTUP. BMJ Open. 2020 Feb 17;10(2).
Kessler TM, La Framboise D, Trelle S, et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and metaanalysis. Eur Urol. 2010 Dec;58(6):865-74.
Peters KM, Kandagatla P, Killinger KA, et al. Clinical outcomes of sacral neuromodulation in patients with neurologic conditions. Urology. 2013 Apr;81(4):738–43.
